Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer

Adithya D Vellal, Korsuk Sirinukunwattana, Kevin H Kensler, Gabrielle M Baker, Andreea L Stancu, Michael E Pyle, Laura C Collins, Stuart J Schnitt, James L Connolly, Mitko Veta, A Heather Eliassen, Rulla M Tamimi, Yujing J Heng
doi: https://doi.org/10.1101/2020.09.02.20186643
Adithya D Vellal
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Korsuk Sirinukunwattana
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
2Institute of Biomedical Engineering (IBME), Department of Engineering Science, Old Road Campus Research Building, University of Oxford, Oxford, UK
3Big Data Institute, University of Oxford, Li Ka Shing Centre for Health Information and Discovery, Oxford, UK
4Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin H Kensler
5Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabrielle M Baker
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreea L Stancu
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E Pyle
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura C Collins
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart J Schnitt
6Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Dana-Farber Cancer Institute-Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James L Connolly
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitko Veta
7Medical Image Analysis Group, Eindhoven University of Technology, Eindhoven, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Heather Eliassen
8Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
9Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rulla M Tamimi
8Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
9Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
10Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yujing J Heng
1Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yheng{at}bidmc.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background New biomarkers of risk may improve breast cancer risk prediction. We developed a computational pathology method to segment benign breast disease (BBD) whole slide images (WSIs) into epithelium, fibrous stroma, and fat. We applied our method to the BBD breast cancer nested case-control study within the Nurses’ Health Studies to assess whether computer-derived tissue composition or a morphometric signature was associated with subsequent risk of breast cancer.

Methods Tissue segmentation and nuclei detection deep-learning networks were established and applied to 3795 WSIs from 293 cases who developed breast cancer and 1132 controls who did not. Percentages of each tissue region were calculated and 615 morphometric features were extracted. Elastic net regression was used to create a breast cancer morphometric signature. Associations between breast cancer risk factors and age-adjusted tissue composition among controls were assessed using analysis of covariance. Unconditional logistic regression, adjusting for the matching factors, BBD histological subtypes, parity, menopausal status, and BMI evaluated the relationship between tissue composition and breast cancer risk.

Results Among controls, BBD subtypes, parity, and number of births were differentially associated with all three tissue regions (p< 0.05); select regions were associated with childhood body size, BMI, age of menarche, and menopausal status (p< 0.05). Higher proportion of epithelial tissue was associated with increased breast cancer risk (OR = 1.39, 95% CI 0.91–2.14 comparing highest and lowest quartiles; p-trend< 0.05). No morphometric signature was associated with breast cancer.

Conclusion The amount of epithelial tissue may be incorporated into risk assessment models to improve breast cancer risk prediction.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institute of Health/National Cancer Institute R21CA187642 (RMT), R01CA175080 (RMT), R01CA240341 (RMT, YJH), UM1CA186107 (AHE), and U01 CA176726 (AHE), Susan G. Komen for the Cure IIR13264020 (RMT), Breast Cancer Research Foundation 17-174, the Klarman Family Foundation (YJH), BIDMC High School Summer Research Program (ADV).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the institutional review boards of the Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* co-senior authors

Data Availability

The data that support the findings of this study are available from the Nurses' Health Studies, however they are not publicly available. Investigators interested in using the data can request access, and feasibility will be discussed at an investigators meeting. Limits are not placed on scientific questions or methods, and there is no requirement for co-authorship. Additional data sharing information and policy details can be accessed at http://www.nurseshealthstudy.org/researchers. The source code is available on GitHub

https://github.com/avellal14/BBD_Pipeline

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
Adithya D Vellal, Korsuk Sirinukunwattana, Kevin H Kensler, Gabrielle M Baker, Andreea L Stancu, Michael E Pyle, Laura C Collins, Stuart J Schnitt, James L Connolly, Mitko Veta, A Heather Eliassen, Rulla M Tamimi, Yujing J Heng
medRxiv 2020.09.02.20186643; doi: https://doi.org/10.1101/2020.09.02.20186643
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
Adithya D Vellal, Korsuk Sirinukunwattana, Kevin H Kensler, Gabrielle M Baker, Andreea L Stancu, Michael E Pyle, Laura C Collins, Stuart J Schnitt, James L Connolly, Mitko Veta, A Heather Eliassen, Rulla M Tamimi, Yujing J Heng
medRxiv 2020.09.02.20186643; doi: https://doi.org/10.1101/2020.09.02.20186643

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)